TANYA PASCHEN: Open Payments
NPI 1184171597 · DENISON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 26 payments from 12 companies in 2025. Trend: 2023 $605 · 2024 $801 · 2025 $507
Food & beverage: $507
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $113 |
| Otsuka America Pharmaceutical, Inc. | 4 | $85 |
| ABBVIE INC. | 4 | $74 |
| Corcept Therapeutics | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 3 | $42 |
| Phathom Pharmaceuticals, Inc. | 2 | $31 |
| Lilly USA, LLC | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Viatris Specialty LLC | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
Products named: CAPLYTA, REXULTI, VRAYLAR, Korlym, AIRSUPRA, VOQUEZNA, KISUNLA, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
